Breast cancer patients receiving anthracyclines. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Axilla Neoplastic Cells, Circulating Tumor Cells, Cultured Lymph Nodes MCF-7 Cells Mammary Glands, Human Nipples Neoplastic Stem Cells

Organisms1

Diseases48

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Lymphatic Metastasis Neoplasms Breast Diseases Breast Neoplasms, Male Carcinoma, Lobular Neoplasm Invasiveness Neoplasm Recurrence, Local Neoplastic Cells, Circulating Carcinoma Lung Neoplasms Carcinoma, Intraductal, Noninfiltrating Disease Progression Genetic Predisposition to Disease Neoplasms, Hormone-Dependent Ovarian Neoplasms Bone Neoplasms Carcinoma, Ductal Mammary Neoplasms, Experimental Prostatic Neoplasms Adenocarcinoma Fibrocystic Breast Disease Stomach Neoplasms Neoplasms, Second Primary Colorectal Neoplasms Colonic Neoplasms Heart Diseases Triple Negative Breast Neoplasms Carcinoma in Situ Fatigue Bone Marrow Neoplasms Fibroadenoma Leukemia P388 Pregnancy Complications, Neoplastic Neovascularization, Pathologic Cell Transformation, Neoplastic Neoplasms, Ductal, Lobular, and Medullary Lymphedema Neutropenia Pancreatic Neoplasms Radiodermatitis Recurrence Endometrial Neoplasms Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Neoplasms, Multiple Primary

Chemicals and Drugs69

Anthracyclines Antibiotics, Antineoplastic Naphthacenes Receptor, erbB-2 Receptors, Estrogen Tamoxifen Tumor Markers, Biological Doxorubicin Receptors, Progesterone Daunorubicin Antineoplastic Agents Epirubicin Antineoplastic Agents, Hormonal Cyclophosphamide Fluorouracil Aclarubicin Neoplasm Proteins Taxoids Aromatase Inhibitors Paclitaxel Antibodies, Monoclonal, Humanized BRCA2 Protein Estrogen Receptor alpha Antigens, Neoplasm DNA, Neoplasm Estrogen Antagonists BRCA1 Protein Carubicin Estrogens RNA, Messenger Idarubicin Bridged Compounds Mucin-1 Antibodies, Monoclonal Vinblastine Antineoplastic Agents, Phytogenic Methotrexate Nitriles Estrogen Receptor Modulators Deoxycytidine Selective Estrogen Receptor Modulators Estradiol Razoxane P-Glycoprotein DNA Topoisomerases, Type II Tumor Suppressor Protein p53 Triazoles Ki-67 Antigen Mammaglobin A Receptor, Epidermal Growth Factor Cisplatin Nogalamycin Keratin-19 Cancer Vaccines RNA, Small Interfering Carcinoembryonic Antigen Mitoxantrone Tumor Suppressor Proteins RNA, Neoplasm Antimetabolites, Antineoplastic DNA-Binding Proteins Keratins Antigens, CD24 Estrone Aconitic Acid Diphosphonates Antineoplastic Agents, Alkylating MicroRNAs Transcription Factors

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Prognosis Chemotherapy, Adjuvant Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Mastectomy Disease-Free Survival Survival Analysis Treatment Outcome Mammography Survival Rate Risk Factors Follow-Up Studies Retrospective Studies Case-Control Studies Immunohistochemistry Mastectomy, Segmental Prospective Studies Multivariate Analysis Early Detection of Cancer Combined Modality Therapy Gene Expression Profiling Neoadjuvant Therapy Kaplan-Meier Estimate Sentinel Lymph Node Biopsy Drug Administration Schedule Predictive Value of Tests Reverse Transcriptase Polymerase Chain Reaction Risk Assessment Radiotherapy, Adjuvant Cohort Studies Risk Sensitivity and Specificity Mammary Neoplasms, Experimental Neoplasm Grading Proportional Hazards Models Incidence Breast Self-Examination Radiotherapy Odds Ratio Lymph Node Excision Registries Clinical Trials as Topic Questionnaires Reproducibility of Results Tissue Array Analysis Blotting, Western Logistic Models Tumor Burden Mastectomy, Modified Radical Oligonucleotide Array Sequence Analysis Ultrasonography, Mammary SEER Program Xenograft Model Antitumor Assays Immunoenzyme Techniques Polymerase Chain Reaction Mammaplasty Mastectomy, Radical Drug Screening Assays, Antitumor Neoplasm Transplantation In Situ Hybridization, Fluorescence Transplantation, Heterologous Confidence Intervals Randomized Controlled Trials as Topic Genetic Testing Pilot Projects Transfection Infusions, Intravenous Biopsy, Needle DNA Mutational Analysis Mass Screening Biopsy Flow Cytometry Enzyme-Linked Immunosorbent Assay Molecular Targeted Therapy Regression Analysis Analysis of Variance Radiotherapy Dosage

Psychiatry and Psychology2

Breast Self-Examination Breast Feeding

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Postmenopause Genes, BRCA1 Premenopause Genes, erbB-2 Time Factors Menopause Genetic Predisposition to Disease Genes, BRCA2 Risk Sensitivity and Specificity Cell Proliferation Dose-Response Relationship, Drug Mutation Odds Ratio Apoptosis Gene Amplification Breast Feeding Germ-Line Mutation Genotype Polymorphism, Genetic Signal Transduction Drug Resistance, Multiple Cell Division Cell Survival DNA Methylation Cell Movement Cell Cycle Down-Regulation Genes, p53 Transfection Genes, Neoplasm Promoter Regions, Genetic Cell Growth Processes Up-Regulation Polymorphism, Single Nucleotide Gene Expression Alleles Phenotype Drug Synergism RNA Interference Base Sequence

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Questionnaires SEER Program Molecular Sequence Data Base Sequence

Named Groups3

Survivors European Continental Ancestry Group Asian Continental Ancestry Group

Health Care33

Disease-Free Survival Survival Analysis Treatment Outcome Survival Rate Risk Factors Follow-Up Studies Retrospective Studies Case-Control Studies Prospective Studies Multivariate Analysis Kaplan-Meier Estimate Predictive Value of Tests Risk Assessment Age Factors Cohort Studies Risk Sensitivity and Specificity Proportional Hazards Models Incidence Odds Ratio Registries Clinical Trials as Topic Questionnaires Reproducibility of Results Logistic Models SEER Program Confidence Intervals Randomized Controlled Trials as Topic Genetic Testing Pilot Projects Mass Screening Regression Analysis Analysis of Variance

Geographicals3

United States China Malaysia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Anthracyclines Breast Neoplasms Breast Antibiotics, Antineoplastic Naphthacenes Carcinoma, Ductal, Breast Receptor, erbB-2 Receptors, Estrogen Prognosis Tamoxifen Tumor Markers, Biological Chemotherapy, Adjuvant Neoplasm Metastasis Doxorubicin Receptors, Progesterone Daunorubicin Neoplasm Staging Antineoplastic Agents Epirubicin Antineoplastic Combined Chemotherapy Protocols Cell Line, Tumor Antineoplastic Agents, Hormonal Lymphatic Metastasis Mastectomy Disease-Free Survival Gene Expression Regulation, Neoplastic Neoplasms Breast Diseases Survival Analysis Breast Neoplasms, Male Treatment Outcome Axilla Carcinoma, Lobular Neoplasm Invasiveness Drug Resistance, Neoplasm Cyclophosphamide Fluorouracil Aclarubicin Mammography Survival Rate Risk Factors Neoplasm Recurrence, Local Follow-Up Studies Postmenopause Retrospective Studies Neoplasm Proteins Case-Control Studies Immunohistochemistry Taxoids Genes, BRCA1 Aromatase Inhibitors Mastectomy, Segmental Premenopause Neoplastic Cells, Circulating Carcinoma Prospective Studies Lung Neoplasms Multivariate Analysis Genes, erbB-2 Tumor Cells, Cultured Carcinoma, Intraductal, Noninfiltrating Paclitaxel Lymph Nodes Antibodies, Monoclonal, Humanized Time Factors Early Detection of Cancer Disease Progression Survivors Menopause Genetic Predisposition to Disease Combined Modality Therapy Neoplasms, Hormone-Dependent Gene Expression Profiling Neoadjuvant Therapy Ovarian Neoplasms Kaplan-Meier Estimate Sentinel Lymph Node Biopsy Drug Administration Schedule BRCA2 Protein Bone Neoplasms Estrogen Receptor alpha Predictive Value of Tests Antigens, Neoplasm Reverse Transcriptase Polymerase Chain Reaction DNA, Neoplasm Risk Assessment Estrogen Antagonists BRCA1 Protein MCF-7 Cells Carubicin Estrogens Genes, BRCA2 RNA, Messenger Mice, Nude Idarubicin Bridged Compounds Age Factors Radiotherapy, Adjuvant Cohort Studies Risk

No FAQ available that match "breast cancer patients receiving anthracyclines"